Concert Pharmaceuticals Inc
NASDAQ:CNCE
Income Statement
Earnings Waterfall
Concert Pharmaceuticals Inc
Revenue
|
42k
USD
|
Operating Expenses
|
-160.3m
USD
|
Operating Income
|
-160.3m
USD
|
Other Expenses
|
-3.7m
USD
|
Net Income
|
-164m
USD
|
Income Statement
Concert Pharmaceuticals Inc
Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||
Revenue |
24
N/A
|
24
+2%
|
25
+5%
|
21
-17%
|
5
-77%
|
9
+76%
|
9
-1%
|
8
-4%
|
60
+637%
|
58
-4%
|
67
+16%
|
66
-2%
|
12
-81%
|
11
-14%
|
0
-98%
|
0
-50%
|
0
N/A
|
144
N/A
|
144
N/A
|
154
+7%
|
154
N/A
|
11
-93%
|
11
N/A
|
1
-90%
|
1
N/A
|
1
N/A
|
1
N/A
|
0
N/A
|
6
N/A
|
8
+23%
|
8
N/A
|
8
N/A
|
34
+324%
|
33
-3%
|
33
+0%
|
33
N/A
|
1
-98%
|
0
-93%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(31)
|
(30)
|
(30)
|
(31)
|
(32)
|
(36)
|
(39)
|
(41)
|
(44)
|
(42)
|
(42)
|
(46)
|
(48)
|
(49)
|
(51)
|
(51)
|
(50)
|
(51)
|
(51)
|
(53)
|
(55)
|
(59)
|
(66)
|
(73)
|
(78)
|
(79)
|
(80)
|
(78)
|
(78)
|
(80)
|
(81)
|
(86)
|
(92)
|
(99)
|
(110)
|
(122)
|
(158)
|
(160)
|
|
Selling, General & Administrative |
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(14)
|
(16)
|
(18)
|
(19)
|
(21)
|
(21)
|
(21)
|
(23)
|
(23)
|
(23)
|
(22)
|
(21)
|
(20)
|
(19)
|
(19)
|
(19)
|
(19)
|
(19)
|
(20)
|
(21)
|
(22)
|
(22)
|
(27)
|
(27)
|
|
Research & Development |
(23)
|
(22)
|
(22)
|
(22)
|
(23)
|
(26)
|
(28)
|
(29)
|
(31)
|
(30)
|
(29)
|
(32)
|
(34)
|
(35)
|
(37)
|
(35)
|
(32)
|
(31)
|
(30)
|
(31)
|
(32)
|
(36)
|
(43)
|
(50)
|
(56)
|
(58)
|
(60)
|
(58)
|
(58)
|
(61)
|
(62)
|
(66)
|
(71)
|
(77)
|
(88)
|
(100)
|
(131)
|
(133)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Operating Income |
(7)
N/A
|
(6)
+17%
|
(4)
+27%
|
(10)
-123%
|
(27)
-174%
|
(27)
-2%
|
(31)
-11%
|
(33)
-8%
|
17
N/A
|
15
-7%
|
25
+61%
|
20
-21%
|
(36)
N/A
|
(38)
-8%
|
(51)
-34%
|
(51)
+1%
|
(50)
+1%
|
93
N/A
|
93
-1%
|
101
+9%
|
100
-1%
|
(48)
N/A
|
(56)
-15%
|
(72)
-30%
|
(77)
-7%
|
(78)
-1%
|
(79)
-1%
|
(77)
+2%
|
(71)
+8%
|
(72)
-2%
|
(73)
-1%
|
(78)
-7%
|
(59)
+25%
|
(66)
-13%
|
(78)
-17%
|
(90)
-16%
|
(157)
-76%
|
(160)
-2%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
(0)
|
(1)
|
(2)
|
1
|
0
|
(0)
|
(3)
|
(6)
|
(4)
|
(4)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(10)
N/A
|
(8)
+19%
|
(6)
+24%
|
(11)
-87%
|
(28)
-150%
|
(29)
-3%
|
(32)
-10%
|
(34)
-6%
|
16
N/A
|
15
-6%
|
25
+64%
|
20
-20%
|
(35)
N/A
|
(38)
-8%
|
(51)
-33%
|
(50)
+1%
|
(50)
+1%
|
92
N/A
|
95
+4%
|
104
+9%
|
104
N/A
|
(43)
N/A
|
(56)
-28%
|
(73)
-31%
|
(79)
-8%
|
(79)
+0%
|
(78)
+0%
|
(77)
+2%
|
(71)
+7%
|
(73)
-2%
|
(75)
-3%
|
(77)
-3%
|
(59)
+24%
|
(66)
-13%
|
(80)
-21%
|
(95)
-19%
|
(162)
-70%
|
(164)
-1%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
2
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(10)
|
(8)
|
(6)
|
(11)
|
(28)
|
(29)
|
(32)
|
(34)
|
15
|
15
|
24
|
19
|
(35)
|
(38)
|
(51)
|
(50)
|
(50)
|
90
|
96
|
105
|
104
|
(41)
|
(56)
|
(73)
|
(79)
|
(79)
|
(78)
|
(77)
|
(71)
|
(73)
|
(75)
|
(77)
|
(59)
|
(66)
|
(80)
|
(95)
|
(162)
|
(164)
|
|
Net Income (Common) |
(10)
N/A
|
(8)
+19%
|
(6)
+24%
|
(11)
-87%
|
(28)
-150%
|
(29)
-3%
|
(32)
-10%
|
(34)
-6%
|
15
N/A
|
15
-5%
|
24
+66%
|
19
-20%
|
(35)
N/A
|
(38)
-8%
|
(51)
-33%
|
(50)
+1%
|
(50)
+1%
|
90
N/A
|
96
+7%
|
105
+9%
|
104
0%
|
(41)
N/A
|
(56)
-36%
|
(73)
-31%
|
(79)
-7%
|
(79)
+0%
|
(78)
+0%
|
(77)
+2%
|
(71)
+7%
|
(73)
-2%
|
(75)
-3%
|
(77)
-3%
|
(59)
+24%
|
(66)
-13%
|
(80)
-21%
|
(95)
-19%
|
(162)
-70%
|
(164)
-1%
|
|
EPS (Diluted) |
-0.87
N/A
|
-0.71
+18%
|
-0.54
+24%
|
-1.22
-126%
|
-1.56
-28%
|
-1.59
-2%
|
-1.74
-9%
|
-1.8
-3%
|
0.67
N/A
|
0.66
-1%
|
1.03
+56%
|
0.86
-17%
|
-1.59
N/A
|
-1.71
-8%
|
-2.27
-33%
|
-2.24
+1%
|
-2.15
+4%
|
3.84
N/A
|
4.18
+9%
|
4.5
+8%
|
4.45
-1%
|
-1.76
N/A
|
-2.39
-36%
|
-3.12
-31%
|
-3.31
-6%
|
-3.3
+0%
|
-3.27
+1%
|
-2.64
+19%
|
-2.26
+14%
|
-2.31
-2%
|
-2.29
+1%
|
-2.27
+1%
|
-1.72
+24%
|
-1.95
-13%
|
-2.25
-15%
|
-2.59
-15%
|
-3.51
-36%
|
-3.3
+6%
|